Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643912 | 12664391 | 2 | F | 2013 | 20160810 | 20160818 | 20160822 | EXP | BR-009507513-1608BRA007340 | MERCK | 0.00 | E | M | Y | 78.00000 | KG | 20160822 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643912 | 12664391 | 1 | PS | VYTORIN | EZETIMIBESIMVASTATIN | 1 | Oral | 10-20 MG, QD | 21687 | TABLET | QD | ||||||||
| 126643912 | 12664391 | 2 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Oral | 1 TABLET, DAILY | 0 | 1 | DF | TABLET | QD | ||||||
| 126643912 | 12664391 | 3 | C | SOMALGIN | ASPIRINDIHYDROXYALUMINUM AMINOACETATE ANHYDROUSMAGNESIUM CARBONATE | 1 | UNK | 0 | TABLET | ||||||||||
| 126643912 | 12664391 | 4 | C | DENYL (citalopram hydrobromide) | 2 | UNK | 0 | ||||||||||||
| 126643912 | 12664391 | 5 | C | BRILINTA | TICAGRELOR | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126643912 | 12664391 | 1 | Hypertension |
| 126643912 | 12664391 | 2 | Hypertension |
| 126643912 | 12664391 | 3 | Hypertension |
| 126643912 | 12664391 | 4 | Prophylaxis |
| 126643912 | 12664391 | 5 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126643912 | 12664391 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126643912 | 12664391 | Abdominal pain upper | |
| 126643912 | 12664391 | Anaemia | |
| 126643912 | 12664391 | Blood thyroid stimulating hormone | |
| 126643912 | 12664391 | Glaucoma | |
| 126643912 | 12664391 | Haematochezia | |
| 126643912 | 12664391 | Haemorrhage | |
| 126643912 | 12664391 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126643912 | 12664391 | 1 | 2012 | 0 | ||
| 126643912 | 12664391 | 2 | 2012 | 0 | ||
| 126643912 | 12664391 | 3 | 2015 | 0 |